Topic 52: Cervical Disease And Neoplasia -

Molecular assays detect the presence of high-risk viral DNA.

Cervical disease and neoplasia represent a critical spectrum of gynecological health, ranging from benign inflammatory conditions to life-threatening malignancies. The primary driver of neoplastic changes in the cervix is the Human Papillomavirus (HPV), making this field a landmark example of how preventative medicine, screening, and vaccination can dramatically alter the trajectory of a disease. Pathogenesis and the Role of HPV Topic 52: Cervical Disease and Neoplasia

When screening results are abnormal, colposcopy allows for direct visualization of the cervix under magnification. Aceto-white changes and abnormal vascular patterns (punctation or mosaicism) guide the clinician to perform targeted biopsies, which provide the definitive histological diagnosis of CIN 1, 2, or 3. Management of Neoplasia Molecular assays detect the presence of high-risk viral DNA

If neoplasia breaches the basement membrane, it is classified as invasive cancer. Treatment then shifts to radical hysterectomy or radiation combined with chemotherapy, depending on the stage of the disease. Prevention and Future Outlook Pathogenesis and the Role of HPV When screening